-+ 0.00%
-+ 0.00%
-+ 0.00%

Eckert & Ziegler H1 FY26 net income rises 4.67% to €22.4 million; sales increase 0.34% to €149.3 million

PUBT·08/13/2026 05:45:44
Listen to the news
Eckert & Ziegler H1 FY26 net income rises 4.67% to €22.4 million; sales increase 0.34% to €149.3 million
  • Eckert & Ziegler posted H1 2026 sales of €149.3 million, up 0.34% year over year.
  • Adjusted EBIT before special items slipped 5.93% to €33.3 million, while net income climbed 4.67% to €22.4 million.
  • Q2 sales fell 5.21% to €76.4 million, as adjusted EBIT before special items dropped 9.38% to €17.4 million.
  • Medical segment sales edged up to €80.9 million, helped by pharmaceutical radioisotopes; Isotope Products sales were €68.5 million.
  • Management reaffirmed the 2026 outlook for sales of around €320 million and adjusted EBIT before special items of around €80 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eckert & Ziegler SE published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2380722_en) on August 13, 2026, and is solely responsible for the information contained therein.